A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies.

MLA

Klatt, Martin G., et al. “A TCR Mimic CAR T Cell Specific for NDC80 Is Broadly Reactive with Solid Tumors and Hematologic Malignancies.” Blood, vol. 140, no. 8, Aug. 2022, pp. 861–74. EBSCOhost, https://doi.org/10.1182/blood.2021012882.

APA

Klatt, M. G., Dao, T., Yang, Z., Liu, J., Mun, S. S., Dacek, M. M., Luo, H., Gardner, T. J., Bourne, C., Peraro, L., Aretz, Z. E. H., Korontsvit, T., Lau, M., Kharas, M. G., Liu, C., & Scheinberg, D. A. (2022). A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies. Blood, 140(8), 861–874. https://doi.org/10.1182/blood.2021012882

Chicago

Klatt, Martin G, Tao Dao, Zhiyuan Yang, Jianying Liu, Sung Soo Mun, Megan M Dacek, Hanzhi Luo, et al. 2022. “A TCR Mimic CAR T Cell Specific for NDC80 Is Broadly Reactive with Solid Tumors and Hematologic Malignancies.” Blood 140 (8): 861–74. doi:10.1182/blood.2021012882.